| Literature DB >> 28419211 |
Rachel J Fenske1,2, Mark T Cadena2,3, Quincy E Harenda4, Haley N Wienkes2,3, Kathryn Carbajal2,3, Michael D Schaid1,2, Erin Laundre2,3, Allison L Brill2,3, Nathan A Truchan2,3, Harpreet Brar2,3, Jaclyn Wisinski1,2,3, Jinjin Cai5,6, Timothy E Graham5,6, Feyza Engin3,4, Michelle E Kimple1,2,3,7.
Abstract
The α-subunit of the heterotrimeric Gz protein, Gαz, promotes β-cell death and inhibits β-cell replication when pancreatic islets are challenged by stressors. Thus, we hypothesized that loss of Gαz protein would preserve functional β-cell mass in the nonobese diabetic (NOD) model, protecting from overt diabetes. We saw that protection from diabetes was robust and durable up to 35 weeks of age in Gαz knockout mice. By 17 weeks of age, Gαz-null NOD mice had significantly higher diabetes-free survival than wild-type littermates. Islets from these mice had reduced markers of proinflammatory immune cell infiltration on both the histological and transcript levels and secreted more insulin in response to glucose. Further analyses of pancreas sections revealed significantly fewer terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL)-positive β-cells in Gαz-null islets despite similar immune infiltration in control mice. Islets from Gαz-null mice also exhibited a higher percentage of Ki-67-positive β-cells, a measure of proliferation, even in the presence of immune infiltration. Finally, β-cell-specific Gαz-null mice phenocopy whole-body Gαz-null mice in their protection from developing hyperglycemia after streptozotocin administration, supporting a β-cell-centric role for Gαz in diabetes pathophysiology. We propose that Gαz plays a key role in β-cell signaling that becomes dysfunctional in the type 1 diabetes setting, accelerating the death of β-cells, which promotes further accumulation of immune cells in the pancreatic islets, and inhibiting a restorative proliferative response.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28419211 PMCID: PMC5460933 DOI: 10.1210/en.2016-1700
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736